Metir plc (MET), the global provider of fast-response, mobile, and point-of-use water and environmental monitoring technologies, announced several strategic developments that support the commercial advancement of its unique proprietary PFAS detection platform across the UK, Europe, and the US. MET said “The first commercial placement of our PFAS detection technology with Veralto in the US illustrates and provides further validation of the growing demand for rapid, field-deployable PFAS monitoring solutions. Alongside this initial deployment, our planned field testing activities in the UK, proposed machine learning AI-enabled software development, and the agreement to secure full ownership of the underlying PFAS measurement IP, are intended to further strengthen our unique commercial offering in this field and to support future growth opportunities.”
Comment: MET is clearly an interesting prospect and one where there will indeed be significant scope for growth. Perhaps the only missing ingredient apart from most people not having heard of the company, is the way that even those who have heard of it are unlikely to have been able to get to grips with what it does.
Blencowe Resources Plc (BRES) noted that its Joint Broker, Oak Securities, has published an updated research note on the Company following Blencowe’s recent DFS model update for the Orom-Cross Graphite Project in Uganda. In the note, Oak reiterates its BUY rating and a 35.70p target price. Oak highlights the step-change in Orom-Cross scale following maiden resource estimates at Iyan and Beehive, taking the total resource base to 64.3 Mt (a 168% increase since Stage 7), and notes that a significant portion of the resource base (Beehive and Iyan) is not yet included in the DFS calculations.
Comment: We are all of course licking our lips at the prospect of BRES hitting the 35.7p level, versus 8p currently. But more important and imminent than the share price quadrupling is the market appreciating the magnitude of Orom-Cross, and indeed recent expansion of the resource base.
Defence Holdings PLC (ALRT), the UK’s software-led defence technology group, today announces a strategic partnership agreement with Intelligence Management Support Services Limited (“IMSL”) in support of the Company’s accelerator programme for early-stage defence and national security technology companies. ALRT said “This partnership with IMSL represents an important step in the development of our Accelerator ecosystem, providing participating companies with access to practical infrastructure and support designed to help bridge the gap between technology development and operational delivery. We believe creating these pathways will be critical to accelerating the next generation of sovereign defence and national security capabilities.”
Comment: Another fluffy RNS from ALRT, something which if it had been released in the autumn would have led to the share price rocketing. Instead now we are perhaps overdue financials on such announcements, rather than another cosy hand holding deal with a sector counterparty.
Further to its announcement dated 5 May 2026 and entitled ‘HUI to enter military market with Fortress Fuel’, Hydrogen Utopia International PLC (HUI), a pioneer in transforming non-recyclable mixed waste into clean hydrogen, carbon-free fuels and advanced materials especially SAF (Sustainable Aviation Fuel) is delighted to announce the creation of Fortress Fuel Limited, a dedicated subsidiary established to address what the Board believes are compelling and fast-moving opportunities in defence energy and fuel security. Fortress Fuel is currently in preliminary discussions with a number of organisations in the defence sector, and the Board believes that there is increasing focus on energy security and fuel independence across the military industry.
Comment: Even though we still have the Iran conflict rumbling on, and the jet fuel market is progressing on a wing and a prayer, none of this supply crunch issue has been factored into the HUI share price. Its sustainable jet fuel offering is revolutionary, and perhaps so is the ongoing way the market continues to keep a lid on the stock. How does that work?
Alex Walker, CEO of East Star (EST), the Kazakhstan-focused gold and copper exploration and development company, invites private shareholders for drinks and Q&A in central London on Thursday, 11 June 2026 at 2.45 p.m. BST. East Star is advancing a portfolio of high-quality copper and gold projects across Kazakhstan, anchored by a maiden JORC mineral resource estimate of 20.3Mt at its Verkhuba VMS copper development in an infrastructure-rich region, as well as a strategic joint venture with Endeavour Mining targeting major gold discoveries. The occasion is a chance to discuss how East Star is progressing these projects towards meaningful value inflexions, with strong exploration pipelines across its VMS and porphyry assets, and a copper JV agreement recently signed with Xinhai Mining adding further momentum to the Company’s growing portfolio. Attendance is strictly by RSVP. Please email eaststar@vigoconsulting.com to register your attendance and to be provided with details of the location.
Comment: Given the way that I am the person who is most consistent in covering EST’s newsflow and with love, it makes sense that I will not be a recipient of an invitation to the forthcoming event. Answers on a postcard.
CMC Markets Plc (CMX) announced its Preliminary Results. Net operating income up 15% and PBT up 20% with strong financial performance and accelerated strategic delivery. Scaling at pace through institutional and B2B partnerships. Strong start and positive outlook for FY2027. Net operating income of £392.6 million (FY2025: £340.1 million), up 15% year-on-year and representing the Group’s best performance on record outside of the FY2021 Covid-impacted year.
Comment: It may be slightly uncharitable to suggest that in the current volatile environment, which should be like falling off a log, even Coco the Clown could deliver a very strong result for CMCX. That said, a record breaking Australian performance, and other novel initiatives underline the way that the company is certainly not sitting on its hands.
Helium One Global (HE1), the primary helium explorer in Tanzania with a 50% working interest in the Galactica-Pegasus helium development project in Colorado, USA, provides an update following the Blue Star Helium (ASX:BNL) announcement issued today regarding the Galactica Project. The Operator has entered an initial short-term (3 month) helium offtake agreement with a major US industrial gases purchaser, covering early production output from the Pinon Canyon Plant.
Comment: The market appears happy this morning with the announcement of an offtake agreement for HE1’s investee company, and it hints that we shall be actually be treated to production rather than just discovery. Indeed, there is still dearth of production amongst listed plays, who seem happy to just enjoy the ride of sentiment currently.
Incanthera (AQSE:INC), the company focused on innovative technologies in dermatology and oncology, announced the strategic acquisition of the Swiss premium skincare brand Énielle and a financing facility. Together with Skin+CELL, the Company’s existing luxury skin care range, the Directors have also revised the Company’s sales strategy across the enhanced portfolio of products to form the basis of a complete retail sales strategy reset designed to consolidate and compliment the Company’s commercial skincare activities.
Comment: Just when keen followers and users of Skin+CELL were looking forward to news of how sales are going, we heard from INC that it is buying a new brand. Is this to act as a hedge against future Skin+CELL sales, because sales are going so well, or because Enielle was going cheap?
Guardian Metal Resources plc (GMET), a strategic exploration company focused on tungsten in Nevada, USA, announced the discovery of the “Tremor Zone”, a newly identified mineralised zone, within the Company’s 100%-owned Pilot Mountain Tungsten Project, located in Nevada, USA. Following analysis of geological and geophysical datasets, the Company’s in-house technical team identified the Tremor Zone area as one of the Project’s priority exploration targets.
Comment: GMET has been the perfect explorer / developer, and one whose life on the stock market has coincided not only with a massive turnaround for the space, but also an appreciation of how important commodities / minerals security is. Indeed, the company has achieved a half a billion market cap and we are still waiting on it to give us some production.
Altona (REE), the Africa focused critical minerals exploration and development company, announced the receipt of rare earths assay results from its 2025 drilling campaign at Monte Muambe. REE said “These results are highly significant. Widespread HREE enrichment in association with fluorspar, combined with the first identification of xenotime at Monte Muambe, opens a compelling pathway to HREE production as a by-product of our fluorspar operation. If confirmed by ongoing metallurgical work and geological modelling, this would meaningfully enhance the project’s value proposition and add a fourth strategic commodity to Monte Muambe’s already exceptional multi-commodity profile.”
Comment: Shares of REE have more than halved over the past month, with a bounce finally coming off the 200 day moving average at 2.2p. Fans of the company will be hoping that this is the end of the rot caused after the Zeus facility fiasco announcement early in May.
Tertiary Minerals plc (TYM), the explorer focused on energy transition and precious metals in Zambia and Nevada, announced that it has raised £985,000 before expenses through a placing. TYM said “I would like to take the opportunity to thank existing and new shareholders for their support. This capital raise is designed to further advance work on our flagship Target A1 silver oxide discovery. This will include drilling to both infill and test mineralisation extensions, along with metallurgical testwork with the aim of delineating a maiden Mineral Resource Estimate by the end of this year.”
Comment: Just yesterday someone on X noted the attractiveness of TYM as a rehabilitated explorer / developer. Presumably, they did not know that a fundraise was on the way, at this serial fundraising company. Perhaps the aftermath of the raise is now actually the best time to take a look at TYM on the basis that the coast is clear.
Ondine Biomedical Inc. (OBI), a global leader in light-activated antimicrobial therapies to prevent and treat hospital infections, announced its audited financial and operational results for year ended 31 December 2025. Revenues increased by 29% to $2.6 million (2024: $2.0 million), driven by new hospital deployments and increased utilisation within existing accounts. OBI said “Ondine has used the past year to build with discipline and conviction. Completion of patient enrolment in our pivotal LANTERN Phase 3 study, marks a significant milestone in our strategy to bring nasal photodisinfection to the U.S market. Alongside the trial, our growing body of real-world evidence continues to demonstrate the potential of Steriwave to reduce infections, improve patient outcomes and lower healthcare costs.”
Comment: It seems that everyone in the world is aware of how much of a breakthrough OBI’s therapies are, apart from the hospitals et al who will actually be using them. This is a nod of course to the need for testing, but still the revenue jump reminds us that OBI is already on its way, with the share price sure to follow.
CRISM Therapeutics Corporation (CRTX), a UK clinical-stage drug delivery company focused on the localised and sustained delivery of chemotherapy drugs, announced that it has been awarded an £896,088 non-dilutive grant from Innovate UK under the Biomedical Catalyst 2025: Industry-led R&D Large Projects competition. The grant represents 70% of the total £1,280,125 project cost and will support the delivery of Part 1 of CRISM’s open label Phase 2 registration-grade clinical trial for irinotecan-ChemoSeed in patients with surgically resectable glioblastoma (GBM).
Comment: One might have expected a rather better bump to the upside for CRTX shares on the latest grant news, given that it should be very helpful indeed. More work perhaps needs to be done by the company to communicate with the market and wave its arms more aggressively than some of its small cap biotech peers.
GEO Exploration Limited (GEO) confirm that the initial field reconnaissance programme at the Gorge Project in Western Australia has now been completed. This work forms part of the Company’s 2026 exploration programme and follows the recent airborne LiDAR, aerial photography, magnetic and radiometric surveys which were completed ahead of schedule. GEO said “We are pleased to confirm completion of the initial field reconnaissance at Gorge, marking another key step in advancing our 2026 exploration programme. The trip was very positive, with the team completing all planned objectives and gathering valuable geological information that strengthens our understanding of the Gorge Project, and the initial signs are exactly what we were expecting to see.”
Comment: Another day, another RNS from GEO, which is obviously on the case as far as engaging with the market. This profile building is important given how much competition there is in the explorer / developer area for eyeballs, and of course, share buying.
